Eptifibatide Good Manufacturer supply High Quality 148031-34-9
- Molecular Formula:C35H49N11O9S2
- Molecular Weight:831.96
- Appearance/Colour:White powder
- Melting Point:92-98°C
- Refractive Index:1.742
- PSA：374.49000
- Density:1.605 g/cm3
- LogP:1.62840
Eptifibatide (148031-34-9) Usage
Eptifibatide, also known as E592000, is a cyclic heptapeptide containing 6 amino acids and 1 mercaptopropionyl (des-amino cysteinyl) residue. It is an arginine-glycine-aspartate (RGD) mimetic that reversibly binds to platelets, playing a crucial role in reducing the risk of cardiac ischemic events. Chemically, it is represented as N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-Llysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic (1→6)-disulfide. Eptifibatide is produced by solution-phase peptide synthesis, purified by preparative reverse-phase liquid chromatography, and lyophilized.
How to get the best price on Eptifibatide?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Eptifibatide . You can buy high quality, low price Eptifibatide 148031-34-9 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
